{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T15:40:11Z","timestamp":1752507611581,"version":"3.41.2"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,14]]},"DOI":"10.7759\/cureus.87901","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T15:18:33Z","timestamp":1752506313000},"source":"Crossref","is-referenced-by-count":0,"title":["The Evolving Field of Cardio-Rheumatology: Global Patterns and Research Gaps, 1953-2025"],"prefix":"10.7759","author":[{"given":"Olatokun","family":"Akano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluwaremilekun","family":"Tolu-Akinnawo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelechukwu P","family":"Ughagwu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olumide","family":"Akinmoju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selimat","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marvellous","family":"Oluwadare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Layal E","family":"Omaruddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluwamisimi  M","family":"Abib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olamide","family":"Odusola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toluwalase","family":"Awoyemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23018","article-title":"Risk of myocardial infarction and stroke in newly diagnosed systemic lupus erythematosus: a general population-based study","volume":"69","author":"Avi\u00f1a-Zubieta JA","year":"2017","unstructured":"Avi\u00f1a-Zubieta JA, To F, Vostretsova K, De Vera M, Sayre EC, Esdaile JM. Risk of myocardial infarction and stroke in newly diagnosed systemic lupus erythematosus: a general population-based study. Arthritis Care Res (Hoboken). 2017, 69:849-56. 10.1002\/acr.23018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2008.06.011","article-title":"Cardiovascular morbidity and mortality in rheumatoid arthritis","volume":"121","author":"Gabriel SE","year":"2008","unstructured":"Gabriel SE. Cardiovascular morbidity and mortality in rheumatoid arthritis. Am J Med. 2008, 121:S9-14. 10.1016\/j.amjmed.2008.06.011","journal-title":"Am J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2021.06.016","article-title":"Sarcoidosis-related cardiomyopathy: current knowledge, challenges, and future perspectives state-of-the-art review","volume":"28","author":"Gilotra NA","year":"2022","unstructured":"Gilotra NA, Griffin JM, Pavlovic N, et al.. Sarcoidosis-related cardiomyopathy: current knowledge, challenges, and future perspectives state-of-the-art review. J Card Fail. 2022, 28:113-32. 10.1016\/j.cardfail.2021.06.016","journal-title":"J Card Fail"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-021-01070-6","article-title":"Cardiotoxicity of immune checkpoint inhibitors","volume":"23","author":"Patel RP","year":"2021","unstructured":"Patel RP, Parikh R, Gunturu KS, Tariq RZ, Dani SS, Ganatra S, Nohria A. Cardiotoxicity of immune checkpoint inhibitors. Curr Oncol Rep. 2021, 23:79. 10.1007\/s11912-021-01070-6","journal-title":"Curr Oncol Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.joi.2017.08.007","article-title":"bibliometrix: an R-tool for comprehensive science mapping analysis","volume":"11","author":"Aria M","year":"2017","unstructured":"Aria M, Cuccurullo C. bibliometrix: an R-tool for comprehensive science mapping analysis. J Informetr. 2017, 11:959-75. 10.1016\/j.joi.2017.08.007","journal-title":"J Informetr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie DH","year":"2014","unstructured":"Birnie DH, Sauer WH, Bogun F, et al.. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014, 11:1305-23. 10.1016\/j.hrthm.2014.03.043","journal-title":"Heart Rhythm"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-020-00435-x","article-title":"Myocarditis and inflammatory cardiomyopathy: current evidence and future directions","volume":"18","author":"Tsch\u00f6pe C","year":"2021","unstructured":"Tsch\u00f6pe C, Ammirati E, Bozkurt B, et al.. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol. 2021, 18:169-93. 10.1038\/s41569-020-00435-x","journal-title":"Nat Rev Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.107.164558","article-title":"Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice","volume":"102","author":"Vakhrusheva O","year":"2008","unstructured":"Vakhrusheva O, Smolka C, Gajawada P, et al.. Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ Res. 2008, 102:703-10. 10.1161\/CIRCRESAHA.107.164558","journal-title":"Circ Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein R","year":"2014","unstructured":"Blankstein R, Osborne M, Naya M, et al.. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol. 2014, 63:329-36. 10.1016\/j.jacc.2013.09.022","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp249","article-title":"Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study","volume":"30","author":"Frustaci A","year":"2009","unstructured":"Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J. 2009, 30:1995-2002. 10.1093\/eurheartj\/ehp249","journal-title":"Eur Heart J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(01)01978-6","article-title":"Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone","volume":"88","author":"Yazaki Y","year":"2001","unstructured":"Yazaki Y, Isobe M, Hiroe M, et al.. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol. 2001, 88:1006-10. 10.1016\/s0002-9149(01)01978-6","journal-title":"Am J Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.120.007405","article-title":"Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document","volume":"13","author":"Ammirati E","year":"2020","unstructured":"Ammirati E, Frigerio M, Adler ED, et al.. Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document. Circ Heart Fail. 2020, 13:e007405. 10.1161\/CIRCHEARTFAILURE.120.007405","journal-title":"Circ Heart Fail"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.090662","article-title":"The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience","volume":"53","author":"Youssef G","year":"2012","unstructured":"Youssef G, Leung E, Mylonas I, et al.. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience. J Nucl Med. 2012, 53:241-8. 10.2967\/jnumed.111.090662","journal-title":"J Nucl Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.01.047","article-title":"Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis","volume":"45","author":"Smedema JP","year":"2005","unstructured":"Smedema JP, Snoep G, van Kroonenburgh MP, van Geuns RJ, Dassen WR, Gorgels AP, Crijns HJ. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol. 2005, 45:1683-90. 10.1016\/j.jacc.2005.01.047","journal-title":"J Am Coll Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin R","year":"2015","unstructured":"Kandolin R, Lehtonen J, Airaksinen J, et al.. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation. 2015, 131:624-32. 10.1161\/CIRCULATIONAHA.114.011522","journal-title":"Circulation"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32226-1","article-title":"Department of error","volume":"396","year":"2020","unstructured":"Department of error. Lancet. 2020, 396.1562. 10.1016\/S0140-6736(20)32226-1","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth GA","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, et al.. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020, 76:2982-3021. 10.1016\/j.jacc.2020.11.010","journal-title":"J Am Coll Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61087-4","article-title":"The burden of non-communicable diseases in South Africa","volume":"12","author":"Mayosi BM","year":"2009","unstructured":"Mayosi BM, Flisher AJ, Lalloo UG, Sitas F, Tollman SM, Bradshaw D. The burden of non-communicable diseases in South Africa. Lancet. 2009, 12:934-47. 10.1016\/S0140-6736(09)61087-4","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61460-3","article-title":"Innovative financing for health: what is truly innovative?","volume":"8","author":"Atun R","year":"2012","unstructured":"Atun R, Knaul FM, Akachi Y, Frenk J. Innovative financing for health: what is truly innovative?. Lancet. 2012, 8:2044-9. 10.1016\/S0140-6736(12)61460-3","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1126\/science.1240474","article-title":"Atypical combinations and scientific impact","volume":"342","author":"Uzzi B","year":"2013","unstructured":"Uzzi B, Mukherjee S, Stringer M, Jones B. Atypical combinations and scientific impact. Science. 2013, 342:468-72. 10.1126\/science.1240474","journal-title":"Science"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby P","year":"2002","unstructured":"Libby P. Inflammation in atherosclerosis. Nature. 2002, 420:868-74. 10.1038\/nature01323","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker PM","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, et al.. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017, 377:1119-31. 10.1056\/NEJMoa1707914","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/378406-the-evolving-field-of-cardio-rheumatology-global-patterns-and-research-gaps-1953-2025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T15:18:34Z","timestamp":1752506314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/378406-the-evolving-field-of-cardio-rheumatology-global-patterns-and-research-gaps-1953-2025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.87901","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,14]]}}}